BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22235270)

  • 1. Disease-free survival after hepatic resection in hepatocellular carcinoma patients: a prediction approach using artificial neural network.
    Ho WH; Lee KT; Chen HY; Ho TW; Chiu HC
    PLoS One; 2012; 7(1):e29179. PubMed ID: 22235270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality predicted accuracy for hepatocellular carcinoma patients with hepatic resection using artificial neural network.
    Chiu HC; Ho TW; Lee KT; Chen HY; Ho WH
    ScientificWorldJournal; 2013; 2013():201976. PubMed ID: 23737707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of artificial neural network and logistic regression models for predicting in-hospital mortality after primary liver cancer surgery.
    Shi HY; Lee KT; Lee HH; Ho WH; Sun DP; Wang JJ; Chiu CC
    PLoS One; 2012; 7(4):e35781. PubMed ID: 22563399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-free survival assessment by artificial neural networks for hepatocellular carcinoma patients after radiofrequency ablation.
    Wu CF; Wu YJ; Liang PC; Wu CH; Peng SF; Chiu HW
    J Formos Med Assoc; 2017 Oct; 116(10):765-773. PubMed ID: 28117199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial neural network model for predicting 5-year mortality after surgery for hepatocellular carcinoma: a nationwide study.
    Shi HY; Lee KT; Wang JJ; Sun DP; Lee HH; Chiu CC
    J Gastrointest Surg; 2012 Nov; 16(11):2126-31. PubMed ID: 22878787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma.
    Mai RY; Lu HZ; Bai T; Liang R; Lin Y; Ma L; Xiang BD; Wu GB; Li LQ; Ye JZ
    Surgery; 2020 Oct; 168(4):643-652. PubMed ID: 32792098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.
    Liu X; Hou Y; Wang X; Yu L; Wang X; Jiang L; Yang Z
    Hepatol Int; 2020 Jul; 14(4):567-576. PubMed ID: 32556865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.
    Cucchetti A; Piscaglia F; Grigioni AD; Ravaioli M; Cescon M; Zanello M; Grazi GL; Golfieri R; Grigioni WF; Pinna AD
    J Hepatol; 2010 Jun; 52(6):880-8. PubMed ID: 20409605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Models for Predicting Quality of Life After Surgical Resection of Hepatocellular Carcinoma: a Prospective Study.
    Chiu CC; Lee KT; Lee HH; Wang JJ; Sun DP; Huang CC; Shi HY
    J Gastrointest Surg; 2018 Oct; 22(10):1724-1731. PubMed ID: 29916106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three data mining models for prediction of advanced schistosomiasis prognosis in the Hubei province.
    Li G; Zhou X; Liu J; Chen Y; Zhang H; Chen Y; Liu J; Jiang H; Yang J; Nie S
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006262. PubMed ID: 29447165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.
    Hao K; Luk JM; Lee NP; Mao M; Zhang C; Ferguson MD; Lamb J; Dai H; Ng IO; Sham PC; Poon RT
    BMC Cancer; 2009 Nov; 9():389. PubMed ID: 19886989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis.
    Ioannou GN; Tang W; Beste LA; Tincopa MA; Su GL; Van T; Tapper EB; Singal AG; Zhu J; Waljee AK
    JAMA Netw Open; 2020 Sep; 3(9):e2015626. PubMed ID: 32870314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.
    Qiao G; Li J; Huang A; Yan Z; Lau WY; Shen F
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2014-20. PubMed ID: 24989634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a predictive score for perioperative transfusion in patients with hepatocellular carcinoma undergoing liver resection.
    Wang HQ; Yang J; Yang JY; Wang WT; Yan LN
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):394-400. PubMed ID: 26256084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.
    Shi HY; Wang SN; Wang SC; Chuang SC; Chen CM; Lee KT
    J Surg Oncol; 2014 Apr; 109(5):487-93. PubMed ID: 24293372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an artificial neural network prognostic model after gastrectomy for gastric carcinoma: An international multicenter cohort study.
    Li Z; Wu X; Gao X; Shan F; Ying X; Zhang Y; Ji J
    Cancer Med; 2020 Sep; 9(17):6205-6215. PubMed ID: 32666682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot Study.
    Mähringer-Kunz A; Wagner F; Hahn F; Weinmann A; Brodehl S; Schotten S; Hinrichs JB; Düber C; Galle PR; Pinto Dos Santos D; Kloeckner R
    Liver Int; 2020 Mar; 40(3):694-703. PubMed ID: 31943703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
    Xiao GQ; Yang JY; Yan LN
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.